Using the JNK activator anisomycin in GATM-overexpressing cells reversed the inhibitory effects on CCA growth by GATM overexpression, leading the authors to conclude that GATM overexpression inhibits CCA proliferation and aggressiveness by inhibiting JNK/Jun signalling [37]. The gene discussed is JUN; the disease is cholangiocarcinoma.